Food and Drug Administration

Vaccines and Related Biological Products Advisory Committee

November 17, 2005


Licensure of New Pneumococcal Vaccines for Adult Indications, Douglas Pratt, MD, MPH, FDA (HTM) (PPT)

Functional Antibody Activity as Measured by Opsonophagocytosis, Sandra Romero-Steiner, PhD, CDC (PDF) (PPT)

Epidemiology of Invasive Pneumococcal Disease in Adults, SDR Matthew Moore, MD, MPH, CDC (HTM) (PPT)


The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Pneumococcal Vaccine for Adults and Elderly Immunity, Polysaccharides and Conjugates, Jan Poolman, PhD, Bacterial Vaccines R&D (HTM) (PPT)

Basis for Develping a Pneumococcal Conjugate Vaccine for Adults, George Siber, MD, Wyeth Research (HTM) (PPT)

Pneumococcal Immunization in the Elderly (HTM) (PPT)